Современные представления о роли микроорганизмов в индуцировании и развитии атеросклероза

Автор: Купрюшин А.С., Чудаева Д.Г., Федорова М.Г., Латынова И.В., Вишнякова Ж.С., Купрюшина Н.В., Ефимов А.А.

Журнал: Саратовский научно-медицинский журнал @ssmj

Статья в выпуске: 2 т.12, 2016 года.

Бесплатный доступ

В работе отражены и проанализированы более 70 источников, посвященных связи инфекционного процесса и развития атеросклеротических изменений. Резюмировано, что инфицирование и носительство патогенных микроорганизмов оказывает влияние на прогрессирование атеросклероза.

Атеросклероз, вирус простого герпеса 1-го и 2-го типов, кишечная микрофлора, хеликобактер пилори, хламидиоз, цитомегаловирусная инфекция

Короткий адрес: https://sciup.org/14918241

IDR: 14918241

Список литературы Современные представления о роли микроорганизмов в индуцировании и развитии атеросклероза

World Health Organization. The World Health Report 2014. URL: who.int>gho/publications/world_health...2014/en/
Leinonen M, Saikku P. Infections and atherosclerosis. Scandinavian Cardiovascular Journal 2000; 34 (1): 12-20
Ono A, Freed E. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proceedings of the National Academy of Sciences of the United States of America 2001; 98: 13925-13930
Itzhaki RF, Wozniak MA. Herpes simplex virus type 1, apolipoprotein E, and cholesterol: A dangerous liaison in Alzheimer's disease and other disorders. Progress in Lipid Research 2005; 34: 123-131
Sun X, Whittaker GR. Role for influenza virus envelope cholesterol in virus entry and infection. Journal of Virology 2003; 77: 12543-12551
Beer C, Pedersen L, Wrth M. Amphotropic murine leukaemia virus envelope protein is associated with cholesterol rich microdomains. Journal of Virology 2005; 2: 36-45
Chung CS, Huang CY, Chang W. Vaccinia virus penetration requires cholesterol and results in specific viral envelope proteins associated with lipid rafts. Journal of Virology 2005; 79: 1623-1634
Katzman RB, Longnecker R. Cholesterol dependent infection of Burkitt's lymphoma cellines by Epstein -Barr virus. J Gen Virol 2003; 84: 2987-2992
Empig CJ, Goldsmith MA. Association of the caveola vesicular system with cellular entry by filoviruses. J Virol 2002; 76: 5266-5270
Reyes Del Valle J, Chavez Salinas S, Medina F, et al. Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J Virol 2005; 79: 4557-4567
Manie SN, Debreyne S, Vincent S, et al. Measles virus structural components are enriched into lipid raft microdomains: a potential cellular location for virus assembly. J Virol 2000; 74: 305-311
Nakayama M, Hisatsune J, Yamasaki E, et al. Clustering of Helicobacter pylori VacA in lipid rafts, mediated by its receptor, receptor like protein tyrosine phosphatase beta, is required for intoxication in AZ 521 cells. Infect Immun 2006; 74: 6571-6580
Risselada HJ, Marrink SJ. The molecular face of lipid rafts in model membranes. Proc Natl Acad Sci USA 2008;105: 17367-17372
Maziere JC, Landureau JC, Giral P, et al. Lovastatin inhibits HIV-1 expression in H9 human T lymphocytes cultured in cholesterol poor medium. Biomed Pharmacother 1994; 48: 63-67
Campbell SM, Crowe SM, Мак J. Virion associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. Aids 2002; 16: 2253-2261
Guyader M, Kiyokawa E, Abrami L, et al. Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization. J Virol 2002; 76: 10356-10364
Sainz BJ, LaMarca HL, Garry RF, et al. Synergistic inhibition of human cytomegalovirus replication by interferon-alpha, -beta and interferon-gamma. J Virol 2005; 2: 14
Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al. Atherogene investigators: impact of infectious burden on extent and longterm prognosis of atherosclerosis. Circulation 2002; 105: 15-21
Ibrahim Al, Obeid MT, Jouma MJ, et al. Detection of herpes simplex virus, cytomegalovirus and Epstein -Barr virus DNA in atherosclerotic plaques andin unaffected bypass grafts. J ClinVirol 2005; 32(1): 29-32
Schlitt A, Blankenberg S, Weise K, et al. Herpesvirus DNA (Epstein -Barr virus, herpes simplex virus, cytomegalovirus) in circulating monocytes of patients with coronary artery disease. Acta Cardiol 2005; 60 (6): 605-610
Shi Y, Tokunaga O. Herpesvirus (HSV1, EBV and CMV) infections in atherosclerotic compared with non-atherosclerotic aortic tissue. Pathol Int2002; 52 (1): 31-39
Benditt EP, Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 1977; 70: 1753-1756
Ганджа И.М. Механизм влияния вирусной инфекции на поражение сосудов и миокарда. Медичний BceceiT 2001; 1:21
Milnich J, Adam E, De Bakey M. Cytomegalovirus and atherosclerosis. Arch Immunol Ther Exp (Warsz) 1996; 44 (5-6): 297-302
Fabricant CG, Fabricant J, Minick CR, et al. Atheroarteriosclerosis induced by infection with herpesvirus. Fed Proc 1983; 42 (8): 2476
Hajjar DP, Fabricant CG, Minick CR, et al. Virus-induced atherosclerosis. Amer J Pathol 1986; 122 (1): 62
Сурнин С.А., Собенин И.А., Карагодин В.П. и др. Индуцирующая роль вирусов острых респираторных вирусных инфекций в прогрессии атеросклеротического процесса. Проблемы и перспективы современной науки 2011; 3 (1): 57-58
Muhlestein JB. Chronic infection and coronary artery disease. Med Clin North Am 2000; 84 (1): 123-148
Перемот С.Д., Целуйко В.И., Смелянская М.В. и др. Влияние представителей семейства Herpesviridae на течение ишемической болезни сердца. УкраТнський кардюлоп'чний журнал 2000; 3: 30-33
Emingil G, Buduneli Е, Aliyev A, et al. Association between periodontal disease and acute myocardial infarction. J Periodontol 2000; 71 (12): 1882-1886
Higgins JP, Higgins JA, Higgins PM, et al. Chlamydia pneumoniae and coronary artery disease: legitimized linkages. Expert Rev Cardiovasc Ther 2003; 1 (3):367-384
Kajander EO. Nanobacteriapropagating calcifying nanoparticles. Lett Appl Microbiol 2006; 42 (6): 549-552
Kalayoglu MV, Libby P, Byrne Gl. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA 2002; 288 (21): 2724-2731
Muhlestein JB. Antibiotic treatment of atherosclerosis. Curr Opin Lipidol 2003; 14 (6): 605-614
Rauscher FM, Goldschmidt Clermont PJ, Davis BH, et al. Aging, Progenitor Cell Exhaustion, and Atherosclerosis. Circulation 2003; 108 (4):457-463
Щупакова A.H. Связь вируса простого герпеса с периферическим атеросклерозом. Достижения медицинской науки Беларуси 2003; 8: 117-118
Zhou YF, Leon MB, Waclawiw MA, et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. Engl J Med 2006; 335: 624-630
Гуревич B.C. Роль вирусов гриппа в прогрессировании атеросклероза. В кн.: Кардиология -XXI век: Материалы конф. СПб., 2001; с. 212-213
Филиппов A.E. Суммарная патогенная нагрузка и ее связь с прогрессированием ишемической болезни сердца. Вестник СПб мед. академии им. Мечникова 2004; 3: 22-27
Matsuura Е, Kobayashi К, Tabuchi М, et al. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog Lipid Res 2006; 45 (6): 466-486
Guan XR, Jiang LX, Ma XH, et al. Respiratory Syncytial Virus Infection and Risk of Acute Myocardial Infarction Am J Med Sci 2010; Aug 31
Koskela R, Mutanen P, Sorsa J, et al. Respiratory disease and cardiovascular morbidity. Occup Environ Med 2005; 62 (9): 650-655
Kreutz R, Bliden K, Tantry U, et al. Viral respiratory tract infections increase platelet reactivity and activation: an explanation for the higher rates of myocardial infarction and stroke during viral illness. Journal of Thrombosis and Haemostasis 2005;3:2108-2109
Aburawi E, Liuba P, PesonenE, et al. Acute Respiratory Viral Infections Aggravate Arterial Endothelial Dysfunction in Children With Type 1 Diabetes. Diabetes Care 2004; 27 (4): 2733-2735
Крылов А.А., Столов С.В., Линецкая Н.Э. Роль воспалительных и инфекционных факторов в развитии атеросклероза. Клиническая медицина 1999; 11:60-62
Сумароков А.Б., Лякишев В.Н. Хламидийная инфекция, вызванная Chlamidia pneumonia, и атеросклероз. Клиническая медицина 1999; 7: 4-10
Титов B.H. Кардиальные вопросы патогенеза атеросклероза: настоящее и перспективы. Терапевтический архив 2001; 73 (2): 78-82
Климов И.A., Цепкое Г.А., Позняк А.А. Атеросклероз коронарных сосудов и хламидиоз. Регионарное кровообращение и микроциркуляция 2002; (1): 53-56
Linnanmiaki Е, Leinonen М, Mattila К. Chlamydia pneumoniae-specifie Circulation immune complexes in patients with chronic coronary heart disease. Circulation 1993; 87: 1130-1134
Saikku P, Leinonem M, Mattila K, et al. Chronic Chlamidia pneumonia infection as the risk factor for coronary heart disease in Helsinki heart study. Ann Intern Med 1992; 116 (4): 273-278
Blasi F, Denil F, Ezba M, et al. Detection of Chlamidia pneumoniae but not Helicobacter pylory in atherosclerotic plagues of aortic aneurisms. J Clin Microbiol 1996; 34(11):27-69
Kowalski M, Konturek PC, Pieniazek P, et al. Prevalence of Helicobacter pylori infection in coronary lumen reduction after percutaneous coronary angioplasty. Dig Liver Dis 2001 Apr; 33 (3): 222-229
Osawa H, Kawakami M, Fujii M, et al. Helicobacter pylori infection and coronary heart disease in Japanese patients. Cardiology 2001; 95(1): 14-19
Konturek PC, Kowalsky M, Nasseri R, et al. Detection of Helicobacter pylori specific DNA in human coronary artery atherosclerotic plaques. In: XlVth International Workshop on Gastroduodenal Pathology and Helicobacter pylori. Strasbourg, 6-8 September, 2001
Рудык Ю.С., Смелянская M.B., Перемот С.Д. и др. Связь Helicobacter pylori с ишемической болезнью сердца. Украинский химико-терапевтический журнал 2000; 3: 43-48
Farsak В, Yildirir A, Akyon Y, et al. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. Journal of Clinical Microbiology 2000 Dec; 38 (12): 4408-4411
Pellicano R, Oliaro E, Gandolfo N, et al. Ischaemic cardiovascular disease and Helicobacter pylori: Where is the link. J of Cardiovascular Surgery (Torino) 2000 Dec; 41 (6): 829-833
Anderson JL, Carlquist JF, Muhlestein JB, et al. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 1998 Jul; 32 (1): 35-41
Laurila A, Bloigu A, Nayha S, et al. Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis 1999 Jan; 142 (1): 207-210
Galante A, Pietroiusti A, Carta S, et al. Infection with Helicobacter pylori and leukocyte response in patients with myocardial infarction. Eur J Clin Microbiol Infect Dis 2000 Apr; 19 (4): 298-300
Gassbarrini A, Cremonini F, Armuzzi A, et al. The role of Helicobacter pylori in cardiovascular and cerebrovascular diseases. J Physiol Pharmacol 1999 Dec; 50 (5): 735-742
Famularo G, Trinchieri V, Santini G, De Simone С Infections, atherosclerosis, and coronary heart disease. Ann Ital Med Int Jun 2000 Apr; 15(2): 144-155
Grabczewska Z, Nartowicz E. Infections with Chlamidia pneumoniae, Helicobacter pylori or cytomegalovirus and atherosclerosis. Przegl Lek 1999; 56 (9): 584-587
Zellner C, Chou TM. Antibiotic prophylaxis and treatment of cardiovascular disease.Circulation 1999; 99 (14): 1922-1923
StoneA. Does Helicobacter pylori cause heartdisease. In: 8th United European Gastroenterology Week 25-30 November 2000, Brussels, Belgium
Исаков В.А., Кудрявцева Л.В. Азитромицин (сумамед) -новый компонент антихеликобактерной терапии. Клиническая фармакология и терапия 2000; 9 (1):22-24
Hishiki S, Shiwa Т, Yokoyama Т, et al. Change of cardiovascular risk factors after eradication therapy of Helicobacter pylori. Nippon Shokakibyo Gakkai Zasshi 2001 Jul; 98 (7): 814-821
Paoluzi P, Consolazio A, Borgia Mc, et al. Increased thrombin generation in patients with chronic gastritis and Helicobacter pylori infection. In: 8th United European Gastroenterology Week 25-30 November 2000, Brussels, Belgium
Oderda G, Chiorboli E, Haitink O, et al. Plasma fibrinogen decreases after eradication in children with Helicobacter pylori gastritis. In: Xth International Workshop on Gastroduodenal Pathology and Helicobacter pylori. Septemer 12-14, 1997, Lisbon, Portugal
Wang Z, Klipfell E, Bennett B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease Nature 2011;472:57-63
Tilg H. Obesity, metabolic syndrome, and microbiota: multiple interactions. J Clin Gastroenterol 2010 Oct; 105 (10): 2218-2227
Wang Z, Klipfell E., Bennett BJ.,etal. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472: 57-63. http://www. href='contents.asp?titleid=6837' title='Nature'>Nature.com/Nature/journal/v472/n7341/full/Nature09922.html. (06 April 2011)
Tang W, Wang Z, Levison B, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013; 368: 1575-1584
Jernberg C, Lofmark S, Edlund C, et al. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 2010; 156: 3216-3223
Толстикова ТВ., Брегель Л.В., Киклевич В.Т. и др. Коронарииты у детей. Сибирский медицинский журнал 2009; 2: 110-112.

Еще

Статья научная